Appropriate use of antifungals: impact of an antifungal stewardship program on the clinical outcome of candidaemia in a French University Hospital.


Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 18 09 2018
accepted: 27 12 2018
pubmed: 27 2 2019
medline: 31 8 2019
entrez: 27 2 2019
Statut: ppublish

Résumé

The objective of this study was to compare clinical outcomes of patients with candidaemia before and after implementation of an antifungal stewardship program (AFSP). This study included all consecutive cases of candidaemia identified from January 2012 to December 2015 in a French University Hospital. Data were collected retrospectively for a period of 2 years before implementation of the AFSP, and prospectively for 2 years after. All cases were reviewed by a multidisciplinary panel of experts including infectiologists, a microbiologist and pharmacists to have a complete follow-up of patients. 33 and 37 patients were finally included in the first and second period, respectively. The sites of entry of the candidaemia cases studied were as follows: intraabdominal in 29 cases (41.4%), central venous catheter 21 (30.0%), other or unknown: 20 (28.6%). Infectiologist consultations increased from 36.4 to 86.5% between the two periods with a significative impact on daily blood cultures which were more frequently performed in the second period (p = 0.04), and the use of echinocandins which was more frequent in the second period (97.1% of cases vs 78.8%, p = 0.03). The 3-month mortality rate declined from 36.4% in the first period to 27.0% in the second period (p = 0.4). Despite the insufficient number of candidaemia cases and the presence of other unmodifiable risk factors of mortality which did not allow us to show a significant effect on the 3-month mortality, AFSP had a significant effect on daily blood cultures and echinocandin use as first-line therapy.

Identifiants

pubmed: 30806974
doi: 10.1007/s15010-018-01264-4
pii: 10.1007/s15010-018-01264-4
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-440

Références

Am J Med. 2002 Oct 15;113(6):480-5
pubmed: 12427497
Clin Infect Dis. 2004 Aug 1;39(3):309-17
pubmed: 15306996
J Clin Microbiol. 2005 Apr;43(4):1829-35
pubmed: 15815004
Antimicrob Agents Chemother. 2005 Sep;49(9):3640-5
pubmed: 16127033
Eur J Clin Microbiol Infect Dis. 2006 Jul;25(7):419-25
pubmed: 16773391
Clin Microbiol Rev. 2007 Jan;20(1):133-63
pubmed: 17223626
Infect Control Hosp Epidemiol. 2010 Jul;31(7):722-7
pubmed: 20497042
Clin Microbiol Infect. 2011 Sep;17 Suppl 5:1-12
pubmed: 21884296
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37
pubmed: 23137135
Pharmacotherapy. 2013 Feb;33(2):137-43
pubmed: 23355283
J Antimicrob Chemother. 2014 Jul;69(7):1993-9
pubmed: 24659750
Emerg Infect Dis. 2014 Jul;20(7):1149-55
pubmed: 24960557
Clin Microbiol Infect. 2014 Oct;20(10):954-62
pubmed: 25294340
J Antimicrob Chemother. 2015;70(6):1908-11
pubmed: 25722302
Lancet Infect Dis. 2015 Dec;15(12):1438-49
pubmed: 26411518
N Engl J Med. 2015 Oct 8;373(15):1445-56
pubmed: 26444731
J Antimicrob Chemother. 2016 Nov;71(suppl 2):ii5-ii12
pubmed: 27880664
J Antimicrob Chemother. 2016 Nov;71(suppl 2):ii37-ii42
pubmed: 27880668
J Antimicrob Chemother. 2016 Nov;71(suppl 2):ii43-ii44
pubmed: 27880669
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Ther Adv Infect Dis. 2018 Jan;5(1):3-10
pubmed: 29344355

Auteurs

H Benoist (H)

Service de pharmacie, Pharmacie centrale, Centre Hospitalier Universitaire de Caen, avenue Côte de Nacre, 14033, Caen Cedex 9, France.

S Rodier (S)

Service de pharmacie, Pharmacie centrale, Centre Hospitalier Universitaire de Caen, avenue Côte de Nacre, 14033, Caen Cedex 9, France.

A de La Blanchardière (A)

Service des maladies infectieuses, Centre Hospitalier Universitaire de Caen, Caen Cedex 9, France.

J Bonhomme (J)

Service de microbiologie, Centre Hospitalier Universitaire de Caen, Caen Cedex 9, France.

H Cormier (H)

Service des maladies infectieuses, Centre Hospitalier Universitaire de Caen, Caen Cedex 9, France.

P Thibon (P)

CPias Normandie, Centre Hospitalier Universitaire de Caen, Caen Cedex 9, France.

Guillaume Saint-Lorant (G)

Service de pharmacie, Pharmacie centrale, Centre Hospitalier Universitaire de Caen, avenue Côte de Nacre, 14033, Caen Cedex 9, France. saintlorant-g@chu-caen.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH